Non-interventional Study on Compliance of Inhaled Treatment With Ventavis in Patient With Pulmonary Hypertension (IVENT)

Bayer

Status: Completed

Conditions: Hypertension, Pulmonary

Treatments: Drug: Iloprost (Ventavis, BAYQ6256)

Study type: Observational

Funder types: Industry

Identifiers

NCT01971450

VE1311RU (Other Identifier)

16777

Details and patient eligibility

About

Local, prospective, multicenter, non-comparative, non-interventional, observational study. It is planed to assess compliance of patients with PH (pulmonary hypertension) with the physician's recommendation in real practice.

Enrollment: 89 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Male and female patients ≥ 18 years old
• Diagnosis of PH
• Planned or current treatment with Ventavis (not more than 6 month)

Exclusion criteria

• Contraindications for the use of Ventavis in accordance with the local product information

Trial design

89 participants in 1 patient group

Iloprost

Description:

The patients with pulmonary hypertension with inhaled treatment with Ventavis according to routine practice meeting the criteria of inclusion.

Treatment:

Drug: Iloprost (Ventavis, BAYQ6256)